Quarterly report pursuant to Section 13 or 15(d)

Net Loss Per Share of Common Stock (Details Narrative)

v3.20.4
Net Loss Per Share of Common Stock (Details Narrative) - shares
3 Months Ended
Jan. 31, 2021
Jan. 31, 2020
Stock Options [Member]    
Antidilutive shares 8,659,134 8,407,234
Warrants [Member]    
Antidilutive shares 560,000 500,000